Skip to primary content

Gordon's shares

Gordon's shares

Main menu

  • Home

Post navigation

← Previous Next →

Neoantigen vaccine prevent clear cell renal carcinoma recurrence in small safety trial.

Posted on February 5, 2025 by jgordon

https://gizmodo.com/three-years-after-experimental-vaccine-these-patients-are-still-cancer-free-2000559585

Excellent news. Phase II trials begin.

This entry was posted in share and tagged IFTTT, Pinboard (jgordon) by jgordon. Bookmark the permalink.
Proudly powered by WordPress